Skip to content

Comparision Of Rhus Toxicodendron And Mezereum In The Treatment Of Atopic Dermatitis In Children Aged 2-16 Years

COMPARATIVE STUDY OF RHUS TOXICODENDRON AND MEZEREUM IN ATOPIC DERMATITIS BETWEEN THE AGE GROUP OF 2-16 YEARS - AN EXPERIMENTAL STUDY - ATOPIC DERMATITIS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105356
Enrollment
1000
Registered
2026-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Rhus Toxicodendron: 1)Mode OF Administration Will Be Oral Homoeopathic Globules/ Liquid Dilution. 2)Potency And Repitation Of The Medicine Will Be Decided According To Homoeopathic Prin

Sponsors

DrJui Kewalram Urkude
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases Of Different Socioeconomic Status Will Be Included.Patients Of Both The Sexes.Patients Of Age Group Between 2 Years To 16 Years Of Age.Cases Considered On The Basis Of History And Clinically Diagnosed With Atopic Dermatitis.Patients Willing To Take Part In The Case Study With Their Consent.

Exclusion criteria

Exclusion criteria: Patients Of Age Group Below 2 Years And Above 16 Years Of Age. Patients With Advanced Complicated Pathology. Parents Of The Patients Who Are Not Willing To Take Part In The Study.Presence Of Secondary Skin Infection( E.g Impetigo, Eczema Herpecticum). Childrens With Systemic Disease(E.g Bronchial Asthma , Thyroid Dysfunction).

Design outcomes

Primary

MeasureTime frame
Recovered -Total Disappearance Of All The Clinical Features Of The Condition. Patient Comes In With & General Well- Being Of PatientTimepoint: Period Of Atleast 2-3 months.

Secondary

MeasureTime frame
Improved - Disappearance Of Clinical Features Of The Case Presented By The Patient But Less Severity And General Well-Being Of PatientTimepoint: Within Period Of 3 Months

Countries

India

Contacts

Public ContactDr. Chimanlal Ramchandra Rajpal

Guru Mishri Homoeopathic Medical College

chimanrajpal@gmail.com8149939438

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026